M&A Corner
Hurdle, CloudLIMS Partner to Augment Diagnostic Lab Capabilities21 Feb 2023
What You Should Know: – Hurdle (a Chronomics Inc. brand), a global bio-infrastructure platform that powers end-to-end diagnostics for life... Continue Reading
|
GSK Abandons COVID-19 Collaboration with Vir21 Feb 2023
After nearly three years, the COVID-19 research collaboration between Vir Biotechnology and GSK has largely come to an end, as... Continue Reading
|
Veradigm and Healthverity Partner to Advance Real-World Evidence for Cardiovascular Disease and Diabetes21 Feb 2023
What You Should Know: – Today, Veradigm and HealthVerity announced a collaboration to advance research and improve patient care for... Continue Reading
|
Laborie Expands NICU Footprint with Acquisition of Novonate21 Feb 2023
Leading diagnostic and therapeutic medical technology company, Laborie Medical Technologies Corp. (Laborie), announced that it has acquired Novonate, Inc. (Novonate)... Continue Reading
|
Canada Diagnostic Centres Expands National Footprint with Strategic Acquisitions of Guardian Radiology and the Ultrasound Centre21 Feb 2023
Canada Diagnostic Centres (CDC), a leading provider of medical imaging services, announces the strategic acquisitions of both Guardian Radiology and... Continue Reading
|
Insulet Acquires Bigfoot’s Insulin Pump Patents for $25M21 Feb 2023
Mass.-based insulin-pump maker Insulet acquired assets related to Bigfoot Biomedical’s pump-based automated insulin delivery (AID) technologies for $25 million. Insulet... Continue Reading
|
Clinical Trial Startup Faro Health Raises $20M and More Digital Health Fundings21 Feb 2023
Faro Health, which offers software to help researchers design clinical trials, announced last week it had raised $20 million in... Continue Reading
|
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin21 Feb 2023
DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc.(Nasdaq: CTKB) today announced that Luminex Corporation, a wholly owned subsidiary of DiaSorin,... Continue Reading
|
LegoChemBio Signs License Agreement to Acquire First-in-class Antibody from Elthera21 Feb 2023
LegoChem Biosciences Inc. (KOSDAQ:141080) (hereinafter “LegoChemBio”) announced on February 13, 2023 a license agreement with Elthera AG, a biotechnology company... Continue Reading
|
Financial Strategies Acquisition Corp. Announces Merger with Austin Biosciences Corp, a Texas Biotechnology Platform Company21 Feb 2023
Financial Strategies Acquisition Corp. (Nasdaq: FXCO) (“FXCO”)(the “Company”)., a Special Purpose Acquisition Company led by CEO Alexander V. Schinzing, today... Continue Reading
|